Annual Operating Expenses
$13.12 M
+$2.75 M+26.55%
31 December 2023
Summary:
Sunshine Biopharma annual total operating expenses is currently $13.12 million, with the most recent change of +$2.75 million (+26.55%) on 31 December 2023. During the last 3 years, it has risen by +$12.50 million (+2008.56%). SBFMW annual operating expenses is now at all-time high.SBFMW Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$3.97 M
+$347.97 K+9.60%
30 September 2024
Summary:
Sunshine Biopharma quarterly total operating expenses is currently $3.97 million, with the most recent change of +$347.97 thousand (+9.60%) on 30 September 2024. Over the past year, it has increased by +$1.20 million (+43.43%). SBFMW quarterly operating expenses is now -39.15% below its all-time high of $6.53 million, reached on 31 December 2022.SBFMW Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.6% | +43.4% |
| 3 y3 years | +2008.6% | +653.6% |
| 5 y5 years | +973.4% | +1840.9% |
SBFMW Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2008.6% | -39.1% | +1209.1% |
| 5 y | 5 years | at high | +2008.6% | -39.1% | +8743.9% |
| alltime | all time | at high | >+9999.0% | -39.1% | +362.7% |
Sunshine Biopharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.97 M(+9.6%) |
| June 2024 | - | $3.62 M(-2.2%) |
| Mar 2024 | - | $3.70 M(-1.3%) |
| Dec 2023 | $13.12 M(+26.6%) | $3.76 M(+35.6%) |
| Sept 2023 | - | $2.77 M(-5.9%) |
| June 2023 | - | $2.94 M(-19.5%) |
| Mar 2023 | - | $3.66 M(-44.0%) |
| Dec 2022 | $10.37 M(+306.6%) | $6.53 M(+265.7%) |
| Sept 2022 | - | $1.79 M(+131.4%) |
| June 2022 | - | $771.42 K(-40.0%) |
| Mar 2022 | - | $1.29 M(+323.8%) |
| Dec 2021 | $2.55 M(+309.8%) | $303.46 K(-42.4%) |
| Sept 2021 | - | $527.13 K(+24.6%) |
| June 2021 | - | $422.96 K(-67.4%) |
| Mar 2021 | - | $1.30 M(+259.5%) |
| Dec 2020 | $622.44 K(-4.5%) | $360.87 K(+362.1%) |
| Sept 2020 | - | $78.10 K(-43.6%) |
| June 2020 | - | $138.55 K(+208.5%) |
| Mar 2020 | - | $44.92 K(-82.5%) |
| Dec 2019 | $651.71 K(-46.7%) | $256.96 K(+25.5%) |
| Sept 2019 | - | $204.67 K(+202.0%) |
| June 2019 | - | $67.77 K(-56.5%) |
| Mar 2019 | - | $155.66 K(-4.9%) |
| Dec 2018 | $1.22 M(+42.6%) | $163.61 K(-47.9%) |
| Sept 2018 | - | $313.89 K(-46.5%) |
| June 2018 | - | $586.57 K(+127.5%) |
| Mar 2018 | - | $257.87 K(+59.0%) |
| Dec 2017 | $857.19 K(-13.7%) | $162.18 K(+42.5%) |
| Sept 2017 | - | $113.81 K(-75.9%) |
| June 2017 | - | $472.22 K(+333.3%) |
| Mar 2017 | - | $108.99 K(-67.6%) |
| Dec 2016 | $993.11 K | $336.10 K(+189.7%) |
| Sept 2016 | - | $116.02 K(-75.4%) |
| June 2016 | - | $471.31 K(+576.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $69.68 K(-60.0%) |
| Dec 2015 | $781.99 K(-55.4%) | $174.24 K(+54.1%) |
| Sept 2015 | - | $113.05 K(-69.4%) |
| June 2015 | - | $369.87 K(+196.3%) |
| Mar 2015 | - | $124.83 K(-59.2%) |
| Dec 2014 | $1.76 M(-9.3%) | $306.30 K(+10.4%) |
| Sept 2014 | - | $277.43 K(-63.8%) |
| June 2014 | - | $765.51 K(+88.6%) |
| Mar 2014 | - | $405.87 K(-40.8%) |
| Dec 2013 | $1.94 M(+174.0%) | $685.41 K(+285.7%) |
| Sept 2013 | - | $177.68 K(+16.4%) |
| June 2013 | - | $152.59 K(-83.5%) |
| Mar 2013 | - | $922.89 K(+390.2%) |
| Dec 2012 | $706.68 K(+27.1%) | $188.26 K(-50.0%) |
| Sept 2012 | - | $376.41 K(+266.5%) |
| June 2012 | - | $102.69 K(+161.1%) |
| Mar 2012 | - | $39.33 K(-89.4%) |
| Dec 2011 | $556.20 K(+3.5%) | $372.06 K(+219.5%) |
| Sept 2011 | - | $116.44 K(+606.1%) |
| June 2011 | - | $16.49 K(-66.5%) |
| Mar 2011 | - | $49.22 K(-88.5%) |
| Dec 2010 | $537.38 K(+1960.6%) | $426.95 K(-128.2%) |
| Sept 2010 | - | -$1.51 M(-195.2%) |
| June 2010 | - | $1.59 M(+4483.3%) |
| Mar 2010 | - | $34.65 K(+8.3%) |
| Oct 2009 | - | $32.01 K(+516.5%) |
| July 2009 | - | $5191.00(+110.2%) |
| Apr 2009 | - | $2470.00(-26.3%) |
| Jan 2009 | - | $3353.00(-27.7%) |
| Oct 2008 | - | $4638.00(+9.3%) |
| July 2008 | $26.08 K(+98.7%) | $4243.00(-60.6%) |
| Apr 2008 | - | $10.78 K(+376.0%) |
| Jan 2008 | - | $2265.00(-74.2%) |
| Oct 2007 | - | $8788.00 |
| July 2007 | $13.12 K | - |
FAQ
- What is Sunshine Biopharma annual total operating expenses?
- What is the all time high annual operating expenses for Sunshine Biopharma?
- What is Sunshine Biopharma annual operating expenses year-on-year change?
- What is Sunshine Biopharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly operating expenses year-on-year change?
What is Sunshine Biopharma annual total operating expenses?
The current annual operating expenses of SBFMW is $13.12 M
What is the all time high annual operating expenses for Sunshine Biopharma?
Sunshine Biopharma all-time high annual total operating expenses is $13.12 M
What is Sunshine Biopharma annual operating expenses year-on-year change?
Over the past year, SBFMW annual total operating expenses has changed by +$2.75 M (+26.55%)
What is Sunshine Biopharma quarterly total operating expenses?
The current quarterly operating expenses of SBFMW is $3.97 M
What is the all time high quarterly operating expenses for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly total operating expenses is $6.53 M
What is Sunshine Biopharma quarterly operating expenses year-on-year change?
Over the past year, SBFMW quarterly total operating expenses has changed by +$1.20 M (+43.43%)